Novel media formulations to enhance Chimeric Antigen Receptor (CAR) T-cell potency and anti-tumor cell function for adoptive immunotherapy

被引：0
|
作者：
Ghassemi, S. [1 ,2 ]
Martinez-Becerra, F. [3 ]
Master, A.
Richman, S. A. [1 ,4 ,5 ]
Heo, D. [1 ,2 ]
Leferovich, J. [1 ,2 ]
Tu, Y. [1 ,8 ]
Garcia-Canaveras, J. C. [6 ]
Ayari, A. [3 ]
Lu, Y. [1 ,2 ]
Wang, A. [1 ,2 ]
Rabinowitz, J. D. [6 ,7 ]
Milone, M. C. [1 ,2 ]
O'Connor, R. [1 ,2 ]
机构：
[1] Univ Penn, Ctr Cellular Immunotherapies, Philadelphia, PA 19104 USA
[2] Univ Penn, Pathol & Lab Med, Philadelphia, PA 19104 USA
[3] Nucleus Biol, San Diego, CA USA
[4] Childrens Hosp Philadelphia, Pediat Oncol, Philadelphia, PA 19104 USA
[5] Perelman Sch Med, Philadelphia, PA USA
[6] Princeton Univ, Chem, Princeton, NJ 08544 USA
[7] Princeton Univ, Lewis Singer Integrat Genom, Princeton, NJ 08544 USA
[8] Univ Penn, Biol Phys, Princeton, NJ USA
来源：
CYTOTHERAPY | 2020年 / 22卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
257
引用
收藏
页码：S133 / S133
页数：1
相关论文
共 50 条
  • [31] Chimeric Antigen Receptor (CAR) T-cell Therapy: A New Genetically Engineered Method of Immunotherapy for Cancer
    Singh, Arun Kumar
    Malviya, Rishabha
    Singh, Amrita
    Sundram, Sonali
    Mishra, Sudhanshu
    CURRENT CANCER DRUG TARGETS, 2023, 23 (03) : 199 - 210
  • [32] Non-invasive T cells adoptive immunotherapy for solid tumor with gel anti-tumor T-cell injections
    Tian, Yishen
    Wang, Kai
    Xu, Chunmiao
    Feng, Jiao
    Zhang, Zhi-Ling
    Chemical Engineering Journal, 2022, 439
  • [33] Non-invasive T cells adoptive immunotherapy for solid tumor with gel anti-tumor T-cell injections
    Tian, Yishen
    Wang, Kai
    Xu, Chunmiao
    Feng, Jiao
    Zhang, Zhi-Ling
    CHEMICAL ENGINEERING JOURNAL, 2022, 439
  • [34] Perspectives on Chimeric Antigen Receptor T-Cell immunotherapy for Solid Tumors
    Kosti, Paris
    Maher, John
    Arnold, James N.
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [35] Immunotherapy and chimeric antigen receptor T-cell therapy in hepatocellular carcinoma
    Serrano Uson Junior, Pedro Luiz
    Liu, Alex J.
    Sonbol, Mohamad Bassam
    Borad, Mitesh J.
    Bekaii-Saab, Tanios S.
    CHINESE CLINICAL ONCOLOGY, 2021, 10 (01)
  • [36] Cerebral edema secondary to chimeric antigen receptor T-cell immunotherapy
    Guha-Thakurta, Nandita
    Wierda, William G.
    NEUROLOGY, 2018, 91 (18) : 843 - 843
  • [37] Chimeric antigen receptor T-cell lymphoma immunotherapy: the next questions
    Salaroli, Adriano
    Spilleboudt, Chloe
    Bron, Dominique
    Lewalle, Philippe
    CURRENT OPINION IN ONCOLOGY, 2020, 32 (05) : 434 - 441
  • [38] Chimeric Antigen Receptor T-Cell Immunotherapy Tackles Blood Cancers
    Brower, Vicki
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (04):
  • [39] A Universal Strategy for Adoptive Immunotherapy of Cancer through Use of a Novel T-cell Antigen Receptor
    Urbanska, Katarzyna
    Lanitis, Evripidis
    Poussin, Mathilde
    Lynn, Rachel C.
    Gavin, Brian P.
    Kelderman, Sander
    Yu, Jason
    Scholler, Nathalie
    Powell, Daniel J., Jr.
    CANCER RESEARCH, 2012, 72 (07) : 1844 - 1852
  • [40] Chimeric antigen receptor (CAR) T-cell treatment for mantle cell lymphoma (MCL)
    Tbakhi, Bushra
    Reagan, Patrick M.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2022, 13
12345